Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER...

Por Menderes, Gulden, Bonazzoli, Elena, Bellone, Stefania, Altwerger, Gary, Black, Jonathan D., Dugan, Katherine, Pettinella, Francesca, Masserdotti, Alice, Riccio, Francesco, Bianchi, Anna, Zammataro, Luca, deHaydu, Christopher, Buza, Natalia, Hui, Pei, Wong, Serena, Huang, Gloria S., Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Publicado no Gynecol Oncol (2017)

In vitro and in vivo activity of IMGN853, an Antibody-Drug Conjugate targeting Folate Receptor Alpha linked to DM4, in biologically aggressive endometrial cancers

Por Altwerger, Gary, Bonazzoli, Elena, Bellone, Stefania, Egawa-Takata, Tomomi, Menderes, Gulden, Pettinella, Francesca, Bianchi, Anna, Riccio, Francesco, Feinberg, Jacqueline, Zammataro, Luca, Han, Chanhee, Yadav, Ghanshyam, Dugan, Katherine, Morneault, Ashley, Ponte, Jose F., Buza, Natalia, Hui, Pei, Wong, Serena, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Publicado no Mol Cancer Ther (2018)

A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma

Por Han, Chanhee, Bellone, Stefania, Siegel, Eric R., Altwerger, Gary, Menderes, Gulden, Bonazzoli, Elena, Takata, Tomomi, Pettinella, Francesca, Bianchi, Anna, Riccio, Francesco, Zammataro, Luca, Yadav, Ghanshyam, Marto, Jarrod A., Penet, Marie-France, Levine, Douglas A., Drapkin, Ronny, Patel, Abhijit, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Publicado no Gynecol Oncol (2018)

Inhibition of BET bromodomain proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a biologically aggressive variant of Endometrial Cancer

Por Bonazzoli, Elena, Predolini, Federica, Cocco, Emiliano, Bellone, Stefania, Altwerger, Gary, Menderes, Gulden, Zammataro, Luca, Bianchi, Anna, Pettinella, Francesca, Riccio, Francesco, Han, Chanhee, Yadav, Ghanshyam, Lopez, Salvatore, Manzano, Aranzazu, Manara, Paola, Buza, Natalia, Hui, Pei, Wong, Serena, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Schlessinger, Joseph, Santin, Alessandro D.
Publicado no Clin Cancer Res (2018)

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Por Li, Charles, Bonazzoli, Elena, Bellone, Stefania, Choi, Jungmin, Dong, Weilai, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Manzano, Aranzazu, Bianchi, Anna, Pettinella, Francesca, Manara, Paola, Lopez, Salvatore, Yadav, Ghanshyam, Riccio, Francesco, Zammataro, Luca, Zeybek, Burak, Yang-Hartwich, Yang, Buza, Natalia, Hui, Pei, Wong, Serena, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Zizioli, Valentina, Odicino, Franco, Pecorelli, Sergio, Ardighieri, Laura, Silasi, Dan-Arin, Litkouhi, Babak, Ratner, Elena, Azodi, Masoud, Huang, Gloria S., Schwartz, Peter E., Lifton, Richard P., Schlessinger, Joseph, Santin, Alessandro D.
Publicado no Proc Natl Acad Sci U S A (2019)